M.D. Navarro

2.8k total citations
21 papers, 1.8k citations indexed

About

M.D. Navarro is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, M.D. Navarro has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Medicine, 11 papers in Endocrinology and 7 papers in Epidemiology. Recurrent topics in M.D. Navarro's work include Antibiotic Resistance in Bacteria (18 papers), Escherichia coli research studies (6 papers) and Urinary Tract Infections Management (5 papers). M.D. Navarro is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Escherichia coli research studies (6 papers) and Urinary Tract Infections Management (5 papers). M.D. Navarro collaborates with scholars based in Spain, Australia and United States. M.D. Navarro's co-authors include Jesús Rodríguez‐Baño, Álvaro Pascual, Miguel A. Muniain, Lorena López‐Cerero, Evelio J. Perea, Ramón Pérez-Cano, Luisa Romero, Pilar Retamar, Luis Martínez‐Martínez and Marina de Cueto and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and International Journal of Food Microbiology.

In The Last Decade

M.D. Navarro

20 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.D. Navarro Spain	16	1.5k	714	610	457	396	21	1.8k
N Mariano United States	8	1.2k 0.8×	311 0.4×	452 0.7×	275 0.6×	394 1.0×	9	1.3k
Danai Sofianou Greece	20	1.1k 0.7×	426 0.6×	538 0.9×	243 0.5×	333 0.8×	30	1.5k
Angela Gomez‐Simmonds United States	21	1.1k 0.7×	419 0.6×	388 0.6×	322 0.7×	412 1.0×	34	1.7k
Angela Raffaella Losito Italy	15	1.4k 0.9×	792 1.1×	297 0.5×	603 1.3×	729 1.8×	20	2.1k
Andrew Denisuik Canada	11	1.2k 0.8×	515 0.7×	215 0.4×	349 0.8×	704 1.8×	19	1.4k
S. Bouchillon United States	19	882 0.6×	623 0.9×	271 0.4×	292 0.6×	371 0.9×	34	1.4k
José Ramón Hernández Spain	12	849 0.6×	501 0.7×	249 0.4×	289 0.6×	260 0.7×	14	1.0k
Olympia Zarkotou Greece	15	957 0.6×	300 0.4×	268 0.4×	304 0.7×	398 1.0×	29	1.1k
Katerina Themeli-Digalaki Greece	14	1.1k 0.7×	299 0.4×	427 0.7×	284 0.6×	392 1.0×	17	1.2k
Samuel K. Bouchillon United States	31	1.9k 1.3×	683 1.0×	425 0.7×	825 1.8×	1.1k 2.7×	51	2.6k

Countries citing papers authored by M.D. Navarro

Since Specialization

Citations

This map shows the geographic impact of M.D. Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Navarro more than expected).

Fields of papers citing papers by M.D. Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.D. Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Navarro. The network helps show where M.D. Navarro may publish in the future.

Co-authorship network of co-authors of M.D. Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of M.D. Navarro. A scholar is included among the top collaborators of M.D. Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.D. Navarro. M.D. Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodríguez-Pardo, Dolors, María Dolores del Toro, Laura Guío Carrión, et al.. (2021). Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial. European Journal of Clinical Microbiology & Infectious Diseases. 40(11). 2411–2419. 4 indexed citations

Martín-Gutiérrez, Guillermo, Germán Peñalva, Manuela Aguilar, et al.. (2020). Efficacy and safety of a comprehensive educational antimicrobial stewardship program focused on antifungal use. Journal of Infection. 80(3). 342–349. 16 indexed citations

Morales, Isabel, Lorena López‐Cerero, M.D. Navarro, et al.. (2018). Intestinal colonization due to Escherichia coli ST131: risk factors and prevalence. Antimicrobial Resistance and Infection Control. 7(1). 135–135. 19 indexed citations

Morales, Isabel, Lorena López‐Cerero, José Molina, et al.. (2017). Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes. International Journal of Antimicrobial Agents. 49(4). 498–502. 14 indexed citations

López‐Cerero, Lorena, et al.. (2017). Prevalence and transmission dynamics of Escherichia coli ST131 among contacts of infected community and hospitalized patients. Clinical Microbiology and Infection. 24(6). 618–623. 18 indexed citations

Núñez‐Núñez, María, M.D. Navarro, Nithya Rajendran, et al.. (2017). Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review. BMJ Open. 7(3). e014538–e014538. 5 indexed citations

Navarro, M.D., et al.. (2014). Protocolo diagnóstico y terapéutico de las vaginitis infecciosas: vulvovaginitis candidiásica, tricomoniasis y vaginosis bacteriana. Medicine - Programa de Formación Médica Continuada Acreditado. 11(51). 3029–3032.

López‐Cerero, Lorena, M.D. Navarro, Mar Bellido, et al.. (2013). Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications. Journal of Antimicrobial Chemotherapy. 69(3). 809–814. 57 indexed citations

Egea, Pilar, Lorena López‐Cerero, Lara Serrano, et al.. (2012). Increased raw poultry meat colonization by extended spectrum beta-lactamase-producing Escherichia coli in the south of Spain. International Journal of Food Microbiology. 159(2). 69–73. 73 indexed citations

10.

Rodríguez‐Baño, Jesús, et al.. (2011). -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts. Clinical Infectious Diseases. 54(2). 167–174. 270 indexed citations

11.

López‐Cerero, Lorena, Pilar Egea, Lara Serrano, et al.. (2011). Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A. International Journal of Antimicrobial Agents. 37(4). 365–367. 43 indexed citations

12.

Rodríguez‐Baño, Jesús, et al.. (2011). Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli. Clinical Microbiology and Infection. 18(9). 894–900. 34 indexed citations

13.

Egea, Pilar, Lorena López‐Cerero, M.D. Navarro, Jesús Rodríguez‐Baño, & Álvaro Pascual. (2011). Assessment of the presence of extended-spectrum beta-lactamase-producing Escherichia coli in eggshells and ready-to-eat products. European Journal of Clinical Microbiology & Infectious Diseases. 30(9). 1045–1047. 19 indexed citations

14.

Doi, Yohei, David L. Paterson, Pilar Egea, et al.. (2009). Extended-spectrum and CMY-type b-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clinical Microbiology and Infection. 16(1). 33–38. 115 indexed citations

15.

Rodríguez‐Baño, Jesús, et al.. (2008). Faecal carriage of extended-spectrum -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. Journal of Antimicrobial Chemotherapy. 62(5). 1142–1149. 174 indexed citations

16.

Rodríguez‐Baño, Jesús & M.D. Navarro. (2008). Extended-spectrum β-lactamases in ambulatory care: a clinical perspective. Clinical Microbiology and Infection. 14. 104–110. 47 indexed citations

17.

Rodríguez‐Baño, Jesús, M.D. Navarro, Luis M. Beltrán, et al.. (2007). Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clinical Microbiology and Infection. 14(2). 180–183. 97 indexed citations

18.

Rodríguez‐Baño, Jesús, M.D. Navarro, Luis M. Beltrán, et al.. (2006). Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge. Clinical Infectious Diseases. 43(11). 1407–1414. 229 indexed citations

19.

Rodríguez‐Baño, Jesús, M.D. Navarro, Luisa Romero, et al.. (2005). Clinical and Molecular Epidemiology of Extended-Spectrum β -Lactamase—Producing Escherichia coli as a Cause of Nosocomial Infection or Colonization: Implications for Control. Clinical Infectious Diseases. 42(1). 37–45. 121 indexed citations

20.

Rodríguez‐Baño, Jesús, M.D. Navarro, Luisa Romero, et al.. (2004). Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients. Journal of Clinical Microbiology. 42(3). 1089–1094. 384 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact